GGrantIndex
← Search

PHASE III STUDY OF NUTROPIN THERAPY IN PUBERTAL CHILDREN WITH GH DEFICIENCY

$28,104M01FY2000RRNIH

University Of Virginia Charlottesville, Charlottesville VA

Investigators

Linked publications & trials

Abstract

Growth hormone release increases 2- to 3-fold at puberty in GH sufficient children. To determine if these increased amounts of GH are required for optimal growth, pubertal GH deficient boys and girls will receive GH at one of two doses - the standard 0.3 mg/kg/week or 0.7 mg/kg/week given daily subcutaneously.

View original record on NIH RePORTER →